VREOF — Vireo Growth Inc.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1771706 ·
Last close
$6.01
Market Cap
$346.76M
52W High
$21.75
52W Low
$5.95
ADV30
38,136
Next earnings
2026-11-10
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | 209,300,000 | 95,300,000 | 13,400,000 | -100,000 | 1,273,700,000 | 103,100,000 | 831,200,000 |
| Mar 2026 | 106,200,000 | 59,300,000 | 17,700,000 | -20,300,000 | 928,800,000 | 122,400,000 | 634,700,000 |
| Dec 2025 | 104,510,462 | 56,882,219 | 2,615,971 | -20,372,228 | 817,154,292 | 102,229,759 | 509,729,300 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$26,211,491
Investing CF
$-85,840,549
Financing CF
$76,219,059
CapEx
$-144,316,673
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.69
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-320,000,000
Inventory
$149,400,000
Receivables
$85,700,000
ST Investments
$1,000,000
EBIT TTM
$18,009,937
Pretax Income TTM
$-14,997,089
Interest Exp TTM
$33,007,026
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$430,769,280
EBITDA
$57,845,040
Free Cash Flow
$-223,618,544
Enterprise Value
$742,064,640
Total Cash
$88,800,000
Total Debt
$518,300,000
Shares Out
57,696,895
Trailing EPS
$-1.39
Book Value
$9.55
ROE
-17.8%
ROA
1.7%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 268,769,268 | 10,159,790 | -68,113,908 | 817,154,292 | 509,729,300 | 307,424,992 | 3,711,491 |
| Dec 2024 | 99,384,221 | 18,067,365 | -28,007,509 | 278,862,918 | 223,299,395 | 55,563,523 | -10,234,550 |
| Dec 2023 | 88,133,163 | 10,579,778 | -25,547,089 | 183,263,719 | 199,307,368 | -16,043,649 | -965,906 |
| Dec 2022 | 74,625,867 | -6,939,365 | -42,457,444 | 159,156,403 | 155,715,519 | 3,440,884 | -18,073,265 |
TTM Snapshot
Revenues TTM
$511,665,617
NetIncome TTM
$-67,071,089
OpCashFlow TTM
—
Assets (Latest)
$1,273,700,000
Forward EPS
$1.95
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ASPE | Aspen Neuroscience, Inc. | $348.94M | $12.00 | — |
| CTNM | Contineum Therapeutics, Inc. | $337.62M | $9.55 | — |
| LYEL | Lyell Immunopharma, Inc. | $336.08M | $13.67 | — |
| PEPG | PepGen Inc. | $365.73M | $3.88 | — |
| CYDY | CytoDyn Inc. | $366.64M | $0.25 | — |
News headlines (Yahoo Finance, 1h cache)
VREOF: Vireo Growth's Strong Revenue Growth Supports Price Target of $45.00
2026-08-12 09:20 · Yahoo
Vireo Growth Inc (VREOF) (Q3 2026) Earnings Call Highlights: Revenue Surges 177% on ...
2026-11-10 21:06 · Yahoo
Vireo Growth Inc. Announces Third Quarter 2026 Results
2026-11-10 11:30 · Yahoo
Vireo Growth Inc. Completes Acquisition of FLUENT Corp.
2026-11-09 13:30 · Yahoo
Vireo Growth Inc. Receives Federal DEA Registrations for Florida Medical Cannabis Dispensaries
2026-11-02 22:14 · Yahoo
Vireo Growth to Report Third Quarter 2026 Financial Results on November 10, 2026
2026-11-02 12:00 · Yahoo
Vireo Growth Inc. Announces Financing for New York and Florida Cultivation Facility
2026-10-05 11:30 · Yahoo
Vireo Growth Inc. Announces Put/Call Agreement in Connection with Loan Acquisition
2026-09-29 20:15 · Yahoo
Vireo Growth Inc. Completes Acquisition of M3 Wellness, a Nevada Dispensary
2026-09-21 20:01 · Yahoo
Vireo Growth Inc. Announces Issuance of Shares in Connection with Altmore Settlement
2026-09-17 20:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.